- Report
- February 2021
- 420 Pages
United States
From €2311EUR$2,400USD£1,988GBP
Wellbutrin (bupropion) is a medication used to treat mental disorders such as depression, seasonal affective disorder, and attention deficit hyperactivity disorder. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) that works by increasing the levels of certain neurotransmitters in the brain. It is available in both immediate-release and extended-release formulations. Wellbutrin is generally well-tolerated and has fewer side effects than other antidepressants.
The mental disorders drugs market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global mental disorders drugs market will reach $80 billion by 2027. The market is driven by the increasing prevalence of mental health disorders, the growing awareness of mental health issues, and the availability of new treatments.
Some of the major companies in the Wellbutrin market include GlaxoSmithKline, Pfizer, Mylan, Sun Pharmaceuticals, and Teva Pharmaceuticals. Show Less Read more